Nurix therapeutics announces participation in the 21st annual needham virtual healthcare conference

San francisco, april 04, 2022 (globe newswire) -- nurix therapeutics, inc.  (nasdaq: nrix), a clinical stage biopharmaceutical company developing targeted protein modulation drugs, today announced that arthur t. sands, m.d., ph.d., nurix's president and chief executive officer, will participate in a fireside chat at the 21st annual needham virtual healthcare conference on monday, april 11, 2022 at 2:15 pm et.
NRIX Ratings Summary
NRIX Quant Ranking